TrialEuropean heart journal. Cardiovascular pharmacotherapy2016

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.

D G Kallend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.